JPH0641431B2 - 4-Arylmethylene-5-alkenylidene-2-cyclopentenones - Google Patents
4-Arylmethylene-5-alkenylidene-2-cyclopentenonesInfo
- Publication number
- JPH0641431B2 JPH0641431B2 JP60224919A JP22491985A JPH0641431B2 JP H0641431 B2 JPH0641431 B2 JP H0641431B2 JP 60224919 A JP60224919 A JP 60224919A JP 22491985 A JP22491985 A JP 22491985A JP H0641431 B2 JPH0641431 B2 JP H0641431B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- added
- mmol
- ethyl acetate
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】 〈産業上の利用分野〉 本発明は4−アリールメチレン−5−アルケニリデン−
2−シクロペンテノン類およびその製法に関する。更に
詳細には優れた制ガン作用,抗ウイルス作用を有する新
規な4−アリールメチレン−5−アルケニリデン−2−
シクロペンテノン類およびその製法に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to 4-arylmethylene-5-alkenylidene-
The present invention relates to 2-cyclopentenones and a method for producing the same. More specifically, a novel 4-arylmethylene-5-alkenylidene-2- having excellent anticancer and antiviral effects
The present invention relates to cyclopentenones and a method for producing the same.
〈従来技術〉 ブロスタグランジン類の中では、その骨格構造の中でシ
クロペンタン環に2重結合を有するブロスタグランジン
類が知られており、これらが強い制ガン活性を呈するこ
とが報告されている。例えばPGD2及びその脱水体PGJ2は
10-5〜10-6モル程度の濃度で白血病細胞(L1210)の
増殖を強く抑制することが知られている。<Prior Art> Among brostaglandins, brostaglandins having a double bond in a cyclopentane ring in their skeletal structure are known, and it is reported that these exhibit strong antitumor activity. Has been done. For example, PGD 2 and its dehydrated product PGJ 2 are known to strongly suppress the growth of leukemia cells (L1210) at a concentration of about 10 −5 to 10 −6 mol.
(福島ら、特開昭58−124718;若塚ら、特開昭
59−5155;59−1463参照)。(See Fukushima et al., JP-A-58-124718; Wakazuka et al., JP-A-59-5155; 59-1463).
またPGA1,Δ7−PGA1類,PGA2類(福島,病態生理2
(8),811(1983);癌と化学療法10(9),193
0(1983)参照)にも同様の活性が認められ、これ
らはin vivoにおいても強い制ガン活性を示すことが知
られている。また最近これらの類縁体である4−置換−
5−アルキリデン−2−ジクロベンテノン類の中で海産
ブロスタグランジン類であるクラブロン,クラビリデノ
ン類〔菊地ら,テトラヘドロン・レターズ(Tetrahedron
Lett.),23,5171(1982),24,1549(1983);24,4433(198
3);小林ら,テトラヘドロン・レターズ(Tetrahedron L
ett.),23,5331(1982),ケミカル・アンド。フアーマシ
ユーテイカル・ブレテイン(Chem,Pharm Bull.),31,1440
(1983)参照〕にも同様の活性を示す(福島ら,第42回
日本療学会要旨集856(1983)参照)ことが知られてい
る。さらにPGJ2類似化合物にも同様の活性(若塚ら,特
開昭58-216155,59-5154参照)が知られるようになつ
た。The PGA 1, Δ 7 -PGA 1 class, PGA 2 type (Fukushima, pathophysiology 2
(8), 811 (1983); Cancer and chemotherapy 10 (9), 193
0 (see 1983)), and similar activities are known, and these are known to exhibit strong antitumor activity in vivo. Recently, these analogues, 4-substituted-
Among the 5-alkylidene-2-dicloventenones, marine brostaglandins such as clavron and claviridone [Kikuchi et al., Tetrahedron Letters (Tetrahedron
Lett.), 23,5171 (1982), 24,1549 (1983); 24,4433 (198
3); Kobayashi et al., Tetrahedron L
ett.), 23,5331 (1982), Chemical &. Pharmacy Bulletin (Chem, Pharm Bull.), 31,1440
(See (1983)], the same activity is also shown (see Fukushima et al., 42nd Annual Meeting of Japan Medical Society 856 (1983)). Further, similar activity has also become known for PGJ 2 similar compounds (see Wakatsuka et al., JP-A-58-216155, 59-5154).
〈発明の目的〉 本発明者らはかかる事実に注目し、これら2−シクロペ
ンテノン類の類縁体でエノン官能基にさらに2重結合が
共役している全く新規な構造の4−アリールメチレン−
5−アルケニリデン−2−シクロペンテノン類を得るべ
く鋭意研究を本発明に至つた。<Object of the Invention> The present inventors have paid attention to such a fact, and in these analogs of 2-cyclopentenones, 4-arylmethylene- having a completely novel structure in which a double bond is further conjugated to an enone functional group.
The present invention has been earnestly studied to obtain 5-alkenylidene-2-cyclopentenones.
〈発明の構成及び効果〉 本発明の4−アリールメチレン−5−アルケニリデン−
2−シクロペンテノン類は下記式〔I〕 〔式中、R1はヒドロキシ基、トリ(炭素数1〜4のア
ルキル)シリルオキシ基、テトラヒドロピラニルオキシ
基、アセトキシ基または炭素数1〜6のアルキルオキシ
カルボニル基で置換されていてもよい炭素数1〜10の
アルキル基を、Arはアルキル基、ヒドロキシ基、アル
コキシ基、アルキルオキシカルボニル基およびハロゲン
原子からなる群から選ばれる少なくとも1種の基で置換
されていてもよい全炭素数6〜12のフェニル基を、記
号は単結合で2重結合に関してE体またはZ体を表わ
す。〕 で表わされる。<Structure and Effect of the Invention> 4-Arylmethylene-5-alkenylidene of the present invention
2-Cyclopentenones are represented by the following formula [I] [In the formula, R 1 is a hydroxy group, a tri (alkyl having 1 to 4 carbon) silyloxy group, a tetrahydropyranyloxy group, an acetoxy group or a carbon which may be substituted with an alkyloxycarbonyl group having 1 to 6 carbon. Ar having a number of 1 to 10 and Ar having a total of 6 to 10 carbon atoms which may be substituted with at least one group selected from the group consisting of an alkyl group, a hydroxy group, an alkoxy group, an alkyloxycarbonyl group and a halogen atom. The phenyl group of 12 represents a single bond in the E form or Z form with respect to the double bond. ] Is represented.
上記式〔I〕においてR1はヒドロキシ基、トリ(炭素
数1〜4のアルキル)シリルオキシ基、テトラヒドロピ
ラニルオキシ基、アセトキシ基または炭素数1〜6のア
ルキルオキシカルボニル基で置換されていてもよい炭素
数1〜10のアルキル基を表わす。アルキル基として
は、例えばメチル,エチル,n−プロピル,n−ペンチ
ル,n−ヘキシル,n−デシル等の直鎖状または分岐状
のものをあげることが出来る。In the above formula [I], R 1 may be substituted with a hydroxy group, a tri (alkyl having 1 to 4 carbons) silyloxy group, a tetrahydropyranyloxy group, an acetoxy group or an alkyloxycarbonyl group having 1 to 6 carbons. It represents a good alkyl group having 1 to 10 carbon atoms. Examples of the alkyl group include linear or branched ones such as methyl, ethyl, n-propyl, n-pentyl, n-hexyl and n-decyl.
これらのアルキル基は上記のとおり置換されていてもよ
く、置換基としては、ヒドロキシ基,および保護された
ヒドロキシ基,エステル基がある。保護されたヒドロキ
シ基としてはt−ブチルジメチルシリルオキシ,トリメ
チルシリルオキシ,テトラヒドロピラニルオキシ,アセ
トキシ等を挙げることが出来る。エステル基としてはメ
トキシカルボニル,エトキシカルボニル,n−プロピル
オキシカルボニル,n−ヘキシルオキシカルボニル,フ
エノキシカルボニル,アセトキシメチル,プロピオニル
オキシメチル,ベンゾイルオキシメチル等をあげること
が出来る。これらの置換基は複数個置換されて良い。
尚、上記のR1の定義以外のものは参考例である。These alkyl groups may be substituted as described above, and the substituent includes a hydroxy group, a protected hydroxy group and an ester group. Examples of the protected hydroxy group include t-butyldimethylsilyloxy, trimethylsilyloxy, tetrahydropyranyloxy, acetoxy and the like. Examples of the ester group include methoxycarbonyl, ethoxycarbonyl, n-propyloxycarbonyl, n-hexyloxycarbonyl, phenoxycarbonyl, acetoxymethyl, propionyloxymethyl, benzoyloxymethyl and the like. A plurality of these substituents may be substituted.
It should be noted that those other than the above definition of R 1 are reference examples.
Arは全炭素数6〜12の置換または非置換のフエニル
基であり、置換基としては、メチル,エチル,プロピル
等のアルキル基,ヒドロキシ基,メトキシ基などのアル
コキシ基,メトキシカルボニル,エトキシカルボニル等
のアルキルオキシカルボニル基,フツ素,塩素等のハロ
ゲン基などを挙げることが出来る。これらの置換基はフ
エニル基に対して複数個置換されてよい。ここで「全炭
素数」とは、置換基を構成する炭素数を含む炭素数を意
味する。Ar is a substituted or unsubstituted phenyl group having a total of 6 to 12 carbon atoms, and examples of the substituent include an alkyl group such as methyl, ethyl and propyl, an alkoxy group such as a hydroxy group and a methoxy group, methoxycarbonyl and ethoxycarbonyl. Alkyloxycarbonyl groups, fluorine, halogen groups such as chlorine, etc. can be mentioned. A plurality of these substituents may be substituted on the phenyl group. Here, the "total carbon number" means the carbon number including the carbon number constituting the substituent.
かかる4−アリールメチレン−5−アルケニリデン−2
−シクロペンテノン類の具体例としては例えば、以下の
化合物が挙げられる。Such 4-arylmethylene-5-alkenylidene-2
-Specific examples of cyclopentenones include the following compounds.
(1)4−ベンジリデン−5−(4−ヒドロキシ−2−オ
クテニリデン)−2−シクロペンテノン(化合物A) (2)4−p−フルオロフエニルメチレン−5−(4−ヒ
ドロキシ−2−オクテニリデン)−2−シクロペンテノ
ン (3)4−p−メチルフエニルメチレン−5−(4−ヒド
ロキシ−2−オクテニリデン)−2−シクロペンテノン (4)4−(3,4−ジメトキシフエニル)メチレン−5−
(4−ヒドロキシ−2−オクテニリデン)−2−シクロ
ペンテノン (5)4−ペンジリデン−5−(4,7−ジヒドロキシ−2−
ヘブテニリデン)−2−シクロペンテノン (6)4−p−フルオロフエニルメチレン−5−(4,7−ジ
ヒドロキシ−2−ヘブテニリデン)−2−シクロペンテ
ノン(化合物B) (7)4−p−メチルフエニルメチレン−5−(4,7−ヒド
ロキシ−2−ヘブテニリデン)−2−シクロペンテノン (8)4−(3,4−ジメトキシフエニル)メチレン−5−
(4,7−ジヒドロキシ−2−ヘブテニリデン)−2−シ
クロペンテノン (9)4−ベンジリデン−5−(4−ヒドロキシ−6−メ
トキシカルボニル−2−ヘキセニリデン)−2−シクロ
ペンテノン (10)4−p−フルオロフエニルメチレン−5−(4−ヒ
ドロキシ−6−メトキシカルボニル−2−ヘキセニリデ
ン)−2−シクロペンテノン (11)4−p−メチルフエニルメチレン−5−(4−ヒド
ロキシ−6−メトキシカルボニル−2−ヘキセニリデ
ン)−2−シクロペンテノン (12)4−(3,4−ジメトキシフエニル)メチレン−5−
(4−ヒドロキシ−6−メトキシカルボニル−2−ヘキ
セニリデン)−2−シクロペンテノン (13)化合物(1)〜(12)のアルコールのt−ブチルジメチ
ルシリルエーテル体 (14)化合物(1)〜(12)のアルコールのアセテート体 (15)化合物(9)〜(12)のカルボン酸体 (16)化合物(15)のエチルエステル体 本発明の4−アリールメチレン−5−アルケニリデン−
2−シクロペンテノン類は下記式〔IV〕 PhSCH2Ar ……〔IV〕 〔式中、Arは前記定義に同じ。〕 で表わされるフエニルスルフイド類をリチオ化し、これ
に下記式〔V〕 〔式中、R2はアルコールの保護基を表わす。〕 で表わされる保護された4−ヒドロキシ−2−シクロペ
ンテノン類を反応せしめ、反応物を下記式〔VI〕 〔式中、R1および記号は前記定義に同じ。〕 で表わされるアルデヒド類で補促し、下記式〔VII〕 ……〔VII〕 〔式中、R1,R2,Arおよび記号は前記定義に同じ。〕 で表わされる三成分縮合体を得、これを単離精製するこ
となくR2OHを脱離させ、下記式〔III〕 ……〔III〕 〔式中、R1,Ar,および記号は前記定義に同じ。〕 で表わされる2−シクロペンテノン体を得、これを脱水
反応に付し下記式〔II〕 ……〔II〕 〔式中、R1,Ar,および記号は前記定義に同じ。〕 で表わされるフエニルスルフイド類とし、これを酸化
し、PhSOHを脱離せしめ必要に応じて脱保護反応に付す
ことにより製造される。(1) 4-benzylidene-5- (4-hydroxy-2-octenylidene) -2-cyclopentenone (Compound A) (2) 4-p-fluorophenylmethylene-5- (4-hydroxy-2-octenylidene ) -2-Cyclopentenone (3) 4-p-methylphenylmethylene-5- (4-hydroxy-2-octenylidene) -2-cyclopentenone (4) 4- (3,4-dimethoxyphenyl) Methylene-5
(4-Hydroxy-2-octenylidene) -2-cyclopentenone (5) 4-Pentylidene-5- (4,7-dihydroxy-2-
Hebutenylidene) -2-cyclopentenone (6) 4-p-fluorophenylmethylene-5- (4,7-dihydroxy-2-heptenylidene) -2-cyclopentenone (Compound B) (7) 4-p- Methylphenylmethylene-5- (4,7-hydroxy-2-heptenylidene) -2-cyclopentenone (8) 4- (3,4-dimethoxyphenyl) methylene-5
(4,7-Dihydroxy-2-heptenylidene) -2-cyclopentenone (9) 4-benzylidene-5- (4-hydroxy-6-methoxycarbonyl-2-hexenylidene) -2-cyclopentenone (10) 4 -P-Fluorophenylmethylene-5- (4-hydroxy-6-methoxycarbonyl-2-hexenylidene) -2-cyclopentenone (11) 4-p-methylphenylmethylene-5- (4-hydroxy-6) -Methoxycarbonyl-2-hexenylidene) -2-cyclopentenone (12) 4- (3,4-dimethoxyphenyl) methylene-5-
(4-Hydroxy-6-methoxycarbonyl-2-hexenylidene) -2-cyclopentenone (13) t-butyldimethylsilyl ether of alcohol of compound (1) to (12) (14) compound (1) to ( 12) Acetate of alcohol (15) Carboxylic acid of compounds (9) to (12) (16) Ethyl ester of compound (15) 4-arylmethylene-5-alkenylidene of the present invention
2-Cyclopentenones are represented by the following formula [IV] PhSCH 2 Ar ... [IV] [wherein, Ar is as defined above. ] The phenyl sulfides represented by the formula [In the formula, R 2 represents a protective group for alcohol. ] A protected 4-hydroxy-2-cyclopentenone represented by the following formula is reacted and the reaction product is represented by the following formula [VI] [In the formula, R 1 and the symbols are the same as defined above. ] Promoted with aldehydes represented by the following formula [VII] ... [VII] [wherein R 1 , R 2 , Ar and symbols are the same as defined above. ] To obtain a ternary condensate represented by, which were detached with R 2 OH without isolation and purification, the following formula [III] ... [III] [In the formula, R 1 , Ar, and symbols are the same as defined above. ] A 2-cyclopentenone compound represented by the formula ... [II] [In the formula, R 1 , Ar, and symbols are the same as defined above. ] It manufactures by making it into the phenyl sulfides represented by these, oxidizing this, making PhSOH desorb, and subjecting to deprotection reaction as needed.
上記式〔V〕においてR2はアルコールの保護基を表わ
し、例えばトリ(C1〜C7)炭化水素−シリル基又は水酸
基の酸素原子と共にアセタール結合を形成する基等を挙
げることができる。In the above formula [V], R 2 represents an alcohol protecting group, and examples thereof include a tri (C 1 -C 7 ) hydrocarbon-silyl group or a group forming an acetal bond with the oxygen atom of the hydroxyl group.
トリ(C1〜C7)炭化水素シリル基としては、例えばトリ
メチルシリル,トリエチルシリル,t−ブチルジメチル
シリル基の如きトリ(C1〜C4)アルキルシリル,t−ブ
チルジフエニルシリル基の如きジフエニル(C1〜C4)ア
ルキルシリル又はトリベンジルシリル基等を好ましいも
のとして挙げることができる。Examples of the tri (C 1 -C 7 ) hydrocarbon silyl group include tri (C 1 -C 4 ) alkylsilyl such as trimethylsilyl, triethylsilyl, t-butyldimethylsilyl group, and diphenyl such as t-butyldiphenylsilyl group. Preferable ones are (C 1 -C 4 ) alkylsilyl or tribenzylsilyl groups.
水酸基の酸素原子と共にアセタール結合を形成する基と
しては、例えばメトキシメチル,1−エトキシエチル,
2−メトキシ−2−プロピル,2−エトキシ−2−プロ
ピル,(2−メトキシエトキシ)メチル,ベンジルオキ
シメチル,2−テトラヒドロピラニル,2−テトラヒド
ロフラニルを挙げることができる。Examples of the group that forms an acetal bond with the oxygen atom of the hydroxyl group include methoxymethyl, 1-ethoxyethyl,
2-methoxy-2-propyl, 2-ethoxy-2-propyl, (2-methoxyethoxy) methyl, benzyloxymethyl, 2-tetrahydropyranyl, 2-tetrahydrofuranyl can be mentioned.
本発明の第一の工程は上記式〔IV〕のフエニルスルフイ
ド類のカルバニオンと上記式〔V〕の保護された4−ヒ
ドロキシ−2−シクロペンテノン類及び上記式〔VI〕の
アルデヒド類との三成分連結反応である。フエニルスル
フイド類〔IV〕のカルバニオンは例えばn−ブチルリチ
ウム,sec−ブチルリチウム等の塩基を作用させること
によつて容易に作ることが出来る。このカルバニオンは
りん酸ヘキサメチルメリアミドの存在下に保護された4
−ヒドロキシ−2−シクロペンテノン類〔V〕に共役付
加させ、必要に応じて塩化トリ−n−ブチル錫を添加し
た後に次いでアルデヒド類〔VI〕を加えると一挙にこれ
ら三成分が連結した縮合体〔VII〕が得られる。この工
程の類似の反応は既に知られており〔野上ら,ブレテイ
ン・オブ・ザ・ケミカル・ソサエテイー・オブ・ジヤパ
ン(Bull.Chem.Soe.Japan),55,3043(1982),テトラヘドロ
ン・レターズ(Tet-rahedron Lett.),26,1985(1985)参
照〕,本発明者らはこの方法論を用いて式〔VII〕の原
料を一挙に得たものである。The first step of the present invention is the carbanion of the phenyl sulfides of the above formula [IV], the protected 4-hydroxy-2-cyclopentenones of the above formula [V] and the aldehydes of the above formula [VI]. Is a three-component ligation reaction with. The carbanion of phenyl sulfides [IV] can be easily prepared by reacting a base such as n-butyllithium or sec-butyllithium. This carbanion was protected in the presence of hexamethylmelamide phosphate 4
-Conjugate addition to hydroxy-2-cyclopentenones [V] and, if necessary, tri-n-butyltin chloride and then aldehydes [VI] are added to condense these three components at once. Body [VII] is obtained. A similar reaction of this process is already known [Nogami et al., Bulletin of the Chemical Society of Japan (Bull.Chem.Soe.Japan) , 55, 3043 (1982), Tetrahedron Letters. (See Tet-rahedron Lett.), 26, 1985 (1985)], the present inventors obtained the raw material of the formula [VII] all at once using this methodology.
上記式三成分縮合体〔VII〕は単離することなく、通常
の後処理により、式〔VII〕よりR1OHが脱離した2−シ
クロペンテノン体〔III〕に導びかれる。The above-mentioned three-component condensate [VII] is not isolated but can be converted to a 2-cyclopentenone derivative [III] from which R 1 OH is eliminated from the formula [VII] by a usual post-treatment.
……〔III〕 [式中、R1,Arおよび記号は前記定義に同じ。] 第二の工程では得られた2−シクロペンテノン体〔II
I〕を脱水反応に付す。脱水剤としてN,N′−ジシクロヘ
キシルカルボジイミド(DCC)が好ましく用いられ、(DCC)
は原料に対して1〜10当量好ましくは1〜5当量用い
て10℃〜40℃で不活性の媒体中で反応される。不活
性媒体としてはベンゼン,トルエン等の芳香族炭化水素
類が好ましく用いられる。またこの時反応助剤が用いら
れる。反応助剤として塩化第1銅,臭化第2銅を原料に
対して1〜6当量、好ましくは1〜3当量用いると反応
はスムーズに進行する。反応物は通常の後処理により脱
水生成物〔II〕を与える。 ... [III] [wherein R 1 , Ar and symbols are the same as defined above. ] The 2-cyclopentenone compound obtained in the second step [II
I] is subjected to dehydration reaction. N, N'-dicyclohexylcarbodiimide (DCC) is preferably used as a dehydrating agent, and (DCC)
Is used at 1 to 10 equivalents, preferably 1 to 5 equivalents, relative to the raw materials and reacted at 10 ° C to 40 ° C in an inert medium. Aromatic hydrocarbons such as benzene and toluene are preferably used as the inert medium. At this time, a reaction aid is used. The reaction proceeds smoothly when 1 to 6 equivalents, preferably 1 to 3 equivalents of cuprous chloride and cupric bromide are used as a reaction aid with respect to the raw materials. The reaction product is subjected to a usual post-treatment to give a dehydration product [II].
……〔II〕 〔式中、R1,Arおよび記号は前記定義に同じ。〕 第三の工程は上記式〔III〕を酸化しPhSOHを脱離させる
反応である。スルフイドの硫黄原子の酸化にはm−クロ
ロ安息香酸,過酢酸,等の有機過酸またはメタ過ヨウ素
酸ナトリウムなどの酸化剤が用いられ。特に好ましくは
m−クロロ過安息香酸が用いられる。用いられる酸化剤
の量は原料のスルフイドに対して0.5〜2.0当量、好まし
くは0.8〜1.2当量が用いられる。媒体としては塩化メチ
レン、ジクロロエタン,等のハロゲン化炭化水素類が用
いられ、反応温度は−78℃〜0℃、好ましくは−50
℃〜−20℃で行なわれる。反応は薄層クロマトグラフ
イー(TLC)等で追跡することによつてモニターさ
れ、反応時間は通常は30分〜2時間である。反応後反
応物に重炭酸ソーダ水溶液を加えた後、反応液の温度を
室温付近に戻し、通常の後処理に付す。 ... [II] [wherein R 1 , Ar and symbols are the same as defined above. The third step is a reaction in which the above formula [III] is oxidized to eliminate PhSOH. Oxidizing agents such as m-chlorobenzoic acid, peracetic acid, and other organic peracids, or sodium metaperiodate are used to oxidize the sulfur atom of sulphide. Particularly preferably, m-chloroperbenzoic acid is used. The amount of the oxidizing agent used is 0.5 to 2.0 equivalents, preferably 0.8 to 1.2 equivalents, relative to the raw material sulfide. Halogenated hydrocarbons such as methylene chloride and dichloroethane are used as a medium, and the reaction temperature is -78 ° C to 0 ° C, preferably -50.
It is carried out at -20 ° C. The reaction is monitored by following it by thin layer chromatography (TLC) or the like, and the reaction time is usually 30 minutes to 2 hours. After the reaction, an aqueous solution of sodium bicarbonate is added to the reaction product, the temperature of the reaction liquid is returned to around room temperature, and the usual post-treatment is applied.
かくして下記式〔VIII〕 ……〔VIII〕 〔式中、R1,Arおよび記号は前記定義に同じ。〕 で表わされるスルホキシド類が得られる。このものは粗
生成物としてそのままPhSOHの脱離反応に付される。脱
離反応はベンゼン,トルエン,キシレン等の芳香族炭化
水素中で加熱することによつて達成される。この内特に
好ましくはトルエンが用いられ、加熱温度は還流温度附
近で行なわれる。反応はTLC等によりモニターし、反
応物は通常の後処理をし、シリカゲルカラムクロマトグ
ラフイー等の手段により精製される。また生成物のR1に
おいて保護基された水素基やエステル基がある場合は必
要に応じて脱保護反応に付しても良い。これはそれ自体
公知の方法でより容易に行なうことが出来る。Thus, the following formula [VIII] ... [VIII] [wherein R 1 , Ar and symbols are the same as defined above. ] The sulfoxides represented by this are obtained. This product is directly subjected to the elimination reaction of PhSOH as a crude product. The elimination reaction is achieved by heating in an aromatic hydrocarbon such as benzene, toluene or xylene. Of these, toluene is particularly preferably used, and the heating temperature is around the reflux temperature. The reaction is monitored by TLC or the like, and the reaction product is subjected to usual post-treatment and purified by means such as silica gel column chromatography. If R 1 of the product has a protected hydrogen group or ester group, it may be subjected to a deprotection reaction if necessary. This can be done more easily in a manner known per se.
すなわち保護基の除去は、保護基が水酸基の酸素原子と
共ににアセタール結合を形成する基の場合には、例えば
酢酸、p−トルエンスルホン酸のピリジニウム塩又は陽
イオン交換樹脂等を触媒とし、例えば水,テトラヒドロ
フラン,エチルエーテル,ジオキサン,アセトン,アセ
トニトリル等を反応溶媒とすることにより好適に実施さ
れる。反応は通常−78℃〜+100℃の温度範囲で1
0分〜3日間程度行なわれる。また保護基がトリ(C1〜
C7)炭化水素−シリル基の場合には、例えば酢酸の存在
下に、上記した如き反応溶媒中で同様の温度で同様の時
間実施される。またはフツ化水素酸のアセトニトリル溶
液中でも実施される。That is, when the protecting group is a group that forms an acetal bond with the oxygen atom of the hydroxyl group, for example, acetic acid, a pyridinium salt of p-toluenesulfonic acid or a cation exchange resin is used as a catalyst to remove the protecting group. , Tetrahydrofuran, ethyl ether, dioxane, acetone, acetonitrile and the like are preferably used as a reaction solvent. The reaction is usually carried out in the temperature range of −78 ° C. to + 100 ° C.
It is performed for 0 minutes to 3 days. The protecting group is tri (C 1 ~
C 7) hydrocarbon - in the case of silyl group, for example in the presence of acetic acid, is carried out similar time at the same temperature at such a reaction solvent described above. Alternatively, it is carried out in a solution of hydrofluoric acid in acetonitrile.
目的化合物中にエステル基がある場合、これを加水分解
に付すことができ、例えばリパーゼ等の酵素を用い、水
又は水を含む溶媒中で−10℃〜+60℃の温度範囲で
10分〜24時間程度行なわれる。When the target compound has an ester group, it can be hydrolyzed, and for example, using an enzyme such as lipase, in water or a solvent containing water in a temperature range of -10 ° C to + 60 ° C for 10 minutes to 24 minutes. It takes about an hour.
かくして〔I〕 〔式中、R1,Ar及び記号は前記定義に同じ。〕 で表わされる4−アリールメチレン−5−アルケニリデ
ン−2−シクロペンテノン類が得られる。本発明の化合
物は特にL1210マウス白血病細胞に対して極めて低濃度
(IC501μg/m以下)で強力な抗ガン作用を示し、制
癌剤として極めて有用である。また抗ウイルス活性を有
する化合物としても期待される有用な化合物である。ま
た動物実験においても強い抗ガン活性を示した。例えば
表1にはin vivoのL1210ガン細胞増殖抑制活性を示し
た。Thus [I] [In the formula, R 1 , Ar and symbols are the same as defined above. ] 4-Aryl methylene-5- alkenylidene-2-cyclopentenone represented by the following formula is obtained. The compound of the present invention exhibits a strong anti-cancer effect on L1210 mouse leukemia cells at an extremely low concentration (IC 50 1 μg / m or less), and is extremely useful as an anticancer agent. It is also a useful compound expected as a compound having antiviral activity. It also showed strong anti-cancer activity in animal experiments. For example, Table 1 shows the L1210 cancer cell growth inhibitory activity in vivo.
表2にはin vivoでのP388マウス白血病細胞移植ガンに
対する抗ガン作用を示した。 Table 2 shows the anticancer activity against P388 mouse leukemia cell transplantation cancer in vivo.
実施例1 スルフイド1-1415mg(2.07mmol)のTHF溶液7m
に−76℃でn−ブチルリチウム溶液1.45m(2.26mm
ol)を加え、15分間攪拌した後りん酸ヘキサメチルト
リアミド(HMPA)0.98m(5.63mmol)を加え直ちに保護
された4−ヒドロキシ−2−シクロペンテノン2400
mg(1.89mmol)のTHF溶液1mをすばやく加えた。
10分間攪拌した後、アルデヒド3-1530mg(2.07mmo
l)のTHF溶液1mを低下した。20分間攪拌した
後、飽和塩化アンモニウム水溶液4mを加え、反応液
の温度を室温まで戻し、酢酸エチル20mを加え抽出
し、抽出液を2回水洗した。抽出液は常法により処理し
た後シリカゲルクロマトグラフイー(酢酸エチル:ヘキ
サン=1:8)で精製し目的物の2−シクロペンテノン
体4759mg(収率75%)を得た。 Example 1 Sulfide 1-1 415 mg (2.07 mmol) in THF solution 7 m
N-butyllithium solution 1.45m (2.26mm
ol) and stirred for 15 minutes, and then hexamethyltriamide triphosphate (HMPA) 0.98 m (5.63 mmol) was added immediately to the protected 4-hydroxy-2-cyclopentenone 2 400.
A THF solution of 1 mg (1.89 mmol) was quickly added.
After stirring for 10 minutes, aldehyde 3-1 530 mg (2.07 mmo
1 m of the THF solution of l) was lowered. After stirring for 20 minutes, 4 m of saturated ammonium chloride aqueous solution was added, the temperature of the reaction solution was returned to room temperature, 20 m of ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method and then purified by silica gel chromatography (ethyl acetate: hexane = 1: 8) to obtain the target product, 2-cyclopentenone derivative 4 759 mg (yield 75%).
TLC(酢酸エチル:ヘキサン=1:3);Rf0.654の
スペクトルデータ IR(液膜)(cm-1):3470,3070,3040,2970,2940,2870,1
700,1580,1470,1250,1080,970,835,775,700 実施例2 アリルスルフイド1-1110mg(0.55mmol)のTHF溶液
3mに−76℃でn−ブチルリチウム溶液0.38m
(0.59mmol)を加え、15分間攪拌した後、りん酸ヘキ
サメチルトリアミド(HMPA)0.26m(1.49mmol)を加
え直ちに化合物2106mg(0.50mmol)のTHF溶液0.5
mをすばやく加えた。10分間攪拌した後塩化トリ−
n−ブチルすず0.16m(0.60mmol)を滴下した。15分
間攪拌した後化合物3-1141mg(0.55mmol)のTHF溶
液1mを滴下した。TLC (ethyl acetate: hexane = 1: 3); spectrum data of Rf0.65 4 IR (liquid film) (cm -1 ): 3470,3070,3040,2970,2940,2870,1
700,1580,1470,1250,1080,970,835,775,700 Example 2 Allyl sulfide 1-1 110 mg (0.55 mmol) in THF solution 3 m at -76 ° C. n-butyllithium solution 0.38 m
(0.59 mmol) was added, and the mixture was stirred for 15 minutes, then 0.26 m (1.49 mmol) of phosphoric acid hexamethyltriamide (HMPA) was added and immediately, a THF solution of Compound 2 106 mg (0.50 mmol) 0.5
m was added quickly. After stirring for 10 minutes, tri-chloride
0.16 m (0.60 mmol) of n-butyltin was added dropwise. After stirring for 15 minutes, 1 m of a THF solution of 141 mg (0.55 mmol) of compound 3-1 was added dropwise.
30分間攪拌した後水1mを加え反応液の温度を室温
まで戻し、酢酸エチル4mを加えて抽出し、抽出液を
2回水洗した。抽出液は常法により処理し粗生成物を得
た。6時間放置後粗生成物4とした後シリカゲルクロマ
トグラフイー(酢酸エチル:ヘキサン=1:8)で精製
し目的4224g(収率83%)を得た。After stirring for 30 minutes, 1 m of water was added to bring the temperature of the reaction solution back to room temperature, 4 m of ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method to obtain a crude product. After standing for 6 hours, the crude product 4 was obtained and then purified by silica gel chromatography (ethyl acetate: hexane = 1: 8) to obtain 224 g of the target 4 (yield 83%).
TCC(酢酸エチル:ヘキサン=1:3);Rf0.65 実施例3 アリルスルフイド1-2100mg(0.46mmol)のTHF溶液
3m(0.50mmol)を加え、15分間攪拌した後りん酸ヘ
キサメチルトリアミド(HMPA)0.22m(1.27mmol)を加え
直ちに化合物289mg(0.42mmol)のTHF溶液0.5m
をすばやく加えた。10分攪拌した後塩化トリ−n−ブ
チルすず0.14m(0.52mmol)を滴下した。15分攪拌し
た後化合物3-1 118mg(0.46mmol)のTHF溶液1mを
滴下した。30分攪拌した後水1mを加え反応液の温
度を室温まで戻し、酢酸エチル4mを加えて抽出し、
抽出液を2回水洗した。抽出液は常法により処理し粗生
成物5,6の混合物を得た。6時間放置後粗生成物とし
た後シリカゲルクロマトグラフイー(酢酸エチル:ヘキ
サン=1:3)で精製した目的物である2−シクロペン
テノン体6193mg(収率83%)を得た。TCC (ethyl acetate: hexane = 1: 3); Rf0.65 Example 3 Allyl sulfide 1-2 100 mg (0.46 mmol) in THF solution 3 m (0.50 mmol) was added, and after stirring for 15 minutes, phosphoric acid hexamethyltriamide (HMPA) 0.22 m (1.27 mmol) was added and immediately compound 2 89 mg (0.42 mmol) THF solution 0.5m
Was added quickly. After stirring for 10 minutes, 0.14 m (0.52 mmol) of tri-n-butyltin chloride was added dropwise. After stirring for 15 minutes, 1 m of a THF solution of 118 mg (0.46 mmol) of compound 3-1 was added dropwise. After stirring for 30 minutes, 1 m of water was added, the temperature of the reaction solution was returned to room temperature, and 4 m of ethyl acetate was added for extraction.
The extract was washed twice with water. The extract was treated by a conventional method to obtain a mixture of crude products 5 and 6 . After standing for 6 hours, a crude product was obtained and then purified by silica gel chromatography (ethyl acetate: hexane = 1: 3) to obtain 193 mg (yield: 83%) of 2-cyclopentenone derivative 6 as a target product.
スペクトルデータ IR(液膜,cm-1):3480,3070,2970,2950,2870,1700,16
05,1505,1470,1250,1225,1155,1070,835,775,740,690 実施例4 スルフイド1-2100mg(0.46mmol)のTHF溶液3m
に−76℃でn−ブチルリチウム溶液0.32m(0.50mm
ol)を加え、15分間攪拌した後、りん酸ヘキサメチル
トリアミド(HMPA)0.22m(1.27mmol)を加え直ちに
化合物289mg(0.42mmol)のTHF溶液0.5mをすば
やく加えた。10分間攪拌した後化合物3-1117mg(0.
46mmol)のTHF溶液1mを滴下した。20分間攪拌
した後、飽和塩化アンモニウム水溶液2mを加え、反
応液の温度を室温まで戻し、酢酸エチル10mを加え
抽出し、抽出液を2回水洗した。抽出液は常法により処
理した後、シリカゲルクロマトグラフイー(酢酸エチ
ル:ヘキサン=1:8)で精製し目的物6167mg(収
率72%)を得た。Spectral data IR (liquid film, cm -1 ): 3480,3070,2970,2950,2870,1700,16
05,1505,1470,1250,1225,1155,1070,835,775,740,690 Example 4 3m of THF solution of sulfid 1-2100 mg (0.46 mmol)
N-butyllithium solution 0.32m (0.50mm at -76 ℃)
ol) and stirred for 15 minutes, 0.22 m (1.27 mmol) of phosphoric acid hexamethyltriamide (HMPA) was added, and immediately 0.5 m of a THF solution containing 89 mg (0.42 mmol) of compound 2 was quickly added. After stirring for 10 minutes, compound 3 -117 mg (0.
1 mmol of a THF solution (46 mmol) was added dropwise. After stirring for 20 minutes, saturated ammonium chloride aqueous solution 2m was added, the temperature of the reaction solution was returned to room temperature, ethyl acetate 10m was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method and then purified by silica gel chromatography (ethyl acetate: hexane = 1: 8) to obtain 167 mg (yield 72%) of the target product 6 .
TLC(酢酸エチル:ヘキサン=1:3);Rf0.61 実施例5 アリルスルフイド1-2502mg(2.30mmol)のTHF溶液
8mに−76℃でn−ブチルリチウム溶液1.60m
(2.50mmol)を加え、15分間攪拌した後、りん酸ヘキ
サメチルトリアミド(HMPA)1.09m(6.27mmol)を加
え直ちに化合物2444mg(2.09mmol)のTHF溶液0.8
mをすばやく加えた。10分間攪拌した後、塩化トリ
−n−ブチルすず0.68m(2.51mmol)を滴下した。15
分間攪拌した後、化合物3-2857mg(2.30mmol)のTH
F溶液2mを滴下した。30分間攪拌した後、水2m
を加え、反応液の温度を室温まで戻し、酢酸エチル5
mを加え抽出し、抽出液を2回水洗した。抽出液は常
法により処理し、粗生成物を得た。6時間放置後、生成
物である2−シクロペンテノン体6としシリカゲルクロ
マトグラフイー(酢酸エチル:ヘキサン=1:8)で精
製し、目的物61090mg(収率78%)を得た。TL
C(酢酸エチル:ヘキサン=1:3);Rf0.42,0.51 実施例6 アリルスルフイド1-2229mg(1.05mmol)のTHF溶液
5mに−76℃でn−ブチルリチウム溶液0.73m
(1.14mmol)を加え、15分間攪拌した後、りん酸ヘキ
サメチルトリアミド(HMPA)0.50m(2.87mmol)を加
え直ちに化合物2204mg(0.96mmol)のTHF溶液0.5
mをすばやく加えた。10分攪拌した後、塩化トリ−
n−ブチルすず0.31m(1.14mmol)を滴下した。15分
攪拌した後化合物3-3240mg(1.05mmol)のTHF溶液
1mを滴下した。30分攪拌した後水1mを加え、
反応液の温度を室温まで戻し、酢酸エチルを加え抽出
し、抽出液を2回水洗した。抽出液は常法により処理
し、粗生成物8を得た。6時間放置後粗生成物9としシ
リカゲルクロマトグラフイー(酢酸エチル:ヘキサン=
1:3)で精製し、目的物である2−シクロペンタノン
体9405mg(収率80%)を得た。TLC (ethyl acetate: hexane = 1: 3); Rf0.61 Example 5 Allylsulfide 1-2502 mg (2.30 mmol) in THF solution 8 m at -76 ° C n-butyllithium solution 1.60 m
(2.50 mmol) was added, and the mixture was stirred for 15 minutes, then 1.09 m (6.27 mmol) of phosphoric acid hexamethyltriamide (HMPA) was added and immediately, a THF solution of Compound 2 444 mg (2.09 mmol) 0.8
m was added quickly. After stirring for 10 minutes, tri-n-butyltin chloride (0.68 m, 2.51 mmol) was added dropwise. 15
After stirring for min, TH compound 3 -2857mg (2.30mmol)
2 m of F solution was dripped. After stirring for 30 minutes, water 2m
Was added, the temperature of the reaction solution was returned to room temperature, and ethyl acetate 5
m was added for extraction, and the extract was washed twice with water. The extract was processed by a conventional method to obtain a crude product. After standing for 6 hours, the product, 2-cyclopentenone derivative 6 , was purified by silica gel chromatography (ethyl acetate: hexane = 1: 8) to obtain 1090 mg of the target product 6 (yield 78%). TL
C (ethyl acetate: hexane = 1: 3); Rf0.42,0.51 Example 6 Allyl sulfide 1-2229 mg (1.05 mmol) in THF solution 5 m at -76 ° C n-butyllithium solution 0.73 m
(1.14 mmol) was added and stirred for 15 minutes, then 0.50 m (2.87 mmol) of phosphoric acid hexamethyltriamide (HMPA) was added and immediately, a THF solution of Compound 2 204 mg (0.96 mmol) 0.5
m was added quickly. After stirring for 10 minutes, trichloride
0.31 m (1.14 mmol) of n-butyltin was added dropwise. After stirring for 15 minutes, 1 m of a THF solution of 240 mg (1.05 mmol) of compound 3-3 was added dropwise. After stirring for 30 minutes, add 1 m of water,
The temperature of the reaction solution was returned to room temperature, ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method to obtain a crude product 8 . After standing for 6 hours, the crude product 9 was designated as silica gel chromatography (ethyl acetate: hexane =
The mixture was purified by 1: 3) to obtain the desired product, a 2-cyclopentanone derivative 9 405 mg (yield 80%).
TLC(酢酸エチル:ヘキサン=1:1);Rf0.40 スペクトルデータ IR(液膜,cm-1):3500,3070,2970,2940,1730,1720,17
00,1600,1585,1505,1475,1440,1370,1240,1170,1095,10
65,1025,960,880,845,790,750,690 実施例7 化合物4225mg(0.42mmol)のベンゼン溶液0.5mに
20℃で塩化第一銅92mg(0.93mmol)を加え、続いてN,
N′−ジシクロヘキシルカルボジイミド(DCC)43
5mg(2.11mmol)のベンゼン溶液1mを加えた。4時間
攪拌した後、溶媒として酢酸エチルを用いろ過しろ液を
2回水洗した。TLC (ethyl acetate: hexane = 1: 1); Rf0.40 spectral data IR (liquid film, cm -1 ): 3500,3070,2970,2940,1730,1720,17
00,1600,1585,1505,1475,1440,1370,1240,1170,1095,10
65,1025,960,880,845,790,750,690 Example 7 92 mg (0.93 mmol) of cuprous chloride was added to 0.5 m of a benzene solution of 225 mg (0.42 mmol) of compound 4 at 20 ° C., followed by N,
N'-dicyclohexylcarbodiimide (DCC) 43
1 mg of a benzene solution of 5 mg (2.11 mmol) was added. After stirring for 4 hours, ethyl acetate was used as a solvent, and the filtrate was washed twice with water.
常法によつて得られた油状粗生成物をシリカゲルクロマ
トグラフイー(酢酸エチル:ヘキサン=1:10)を用
いて精製し、目的物10192mg(収率88%)を得
た。The oily crude product obtained by a conventional method was purified by silica gel chromatography (ethyl acetate: hexane = 1: 10) to obtain the desired product 10 192 mg (yield 88%).
TLC(酢酸エチル:ヘキサン=1:3);Rf0.82,0.7
2 高極性成分のスペクタルデータ(10−1) IR(液膜,cm-1):3080,3040,2970,2950,2870,1695,16
35,1580,1470,1250,1085,975,835,775,740,695 実施例8 化合物10-1 188mg(0.36mmol)の塩化メチレン溶液8
mに−40℃でm−クロロ過安息香酸63mg(0.36mmo
l)を加え30分間攪拌した後、重炭酸ソーダ水溶液で中
和し室温まで戻し、塩化メチレン抽出し、抽出液を2回
水洗した。TLC (ethyl acetate: hexane = 1: 3); Rf 0.82,0.7
2 Spectral data of highly polar components (10-1) IR (liquid film, cm -1 ): 3080,3040,2970,2950,2870,1695,16
35,1580,1470,1250,1085,975,835,775,740,695 Example 8 Compound 10-1 188 mg (0.36 mmol) of methylene chloride solution 8
m-chloroperbenzoic acid 63 mg (0.36 mmo at -40 ° C)
l) was added and the mixture was stirred for 30 minutes, neutralized with an aqueous sodium bicarbonate solution, returned to room temperature, extracted with methylene chloride, and the extract was washed twice with water.
常法によつて得られた油状粗生成物11は、そのまま次の
反応を行なつた。The oily crude product 11 obtained by a conventional method was directly subjected to the following reaction.
TLC(酢酸エチル:ヘキサン=1:2);Rf0.56 IR(液膜,cm-1):3080,2970,2950,2870,1700,1635,15
80,1460,1255,1195,1150,1085,1050,980,940,780,745,7
00 実施例9 油状粗生成物11のトルエン溶液20mを還流下で1時
間攪拌した後、トルエンを除去し、シリカゲルクロマト
グラフイー(酢酸エチル:ヘキサン=1:15)で不純
物を除き(ここでは精製できなかつた。)粗生成物12-1
を得た。TLC (ethyl acetate: hexane = 1: 2); Rf 0.56 IR (liquid film, cm −1 ): 3080,2970,2950,2870,1700,1635,15
80,1460,1255,1195,1150,1085,1050,980,940,780,745,7
00 Example 9 20 m of a toluene solution of the oily crude product 11 was stirred under reflux for 1 hour, toluene was removed, and impurities were removed by silica gel chromatography (ethyl acetate: hexane = 1: 15). ) Crude product 12-1
Got
粗生成物12-1をアセトニトリル溶液2mに5%HF0.
4mを加え23℃で6時間攪拌した後、重炭酸ソーダ
水溶液で中和し、酢酸エチル10mを加え抽出し、抽
出液を2回水洗した。抽出液は常法より処理した後シリ
カゲルクロマトグラフイー(酢酸エチル:ヘキサン=
1:6)で精製し、目的物12-265mg(10-1からの収率
61%)を得た。The crude product 12-1 was added to 2 m of an acetonitrile solution with 5% HF0.
After adding 4 m and stirring at 23 ° C. for 6 hours, the solution was neutralized with an aqueous sodium bicarbonate solution, 10 m of ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method and then subjected to silica gel chromatography (ethyl acetate: hexane =
The product was purified by 1: 6) to obtain 65 mg of the desired product 12-2 (yield 61% from 10-1 ).
TLC(酢酸エチル:ヘキサン=1:2); Rf0.47,0.40 (40%)(20%) スペクトルデータ 化合物12-1 TLC;Rf0.73,EtoAc/hex=1/5 IR(液膜,cm-1):3070,2960,2860,1690,1620,1530,14
60,1440,1320,1250,1170,1140,1070,970,830,770,745,6
90 化合物12-2 TLC;Rf0.47,0.40,EtoAc=1/2 低極性成分(E,Z型) IR(液膜,cm-1):3450,3070,2970,2940,2870,1680,16
15,1525,1440,1320,1220,1175,1120,1070,1050,970,82
0,750,695 H NMR;0.89(3H,br),1.1-1.7(6H,br),4.35(1H,m,5-
H),6.35(1H,dd J=6,2Hz,11-H),6.4(1H,m,7-H),6.8-7.2
(3H,m,6-H,8-H,14-H),7.34(5H,S,Ph),8.01(1H,d,J=6H
z,12-H) 高極性成分(E,E型) IR(液膜,cm-1):3450,2960,2945,2860,1680,1615,15
35,1440,1220,1185,1160,1125,975,860,820,750,690 H NMR;0.88(3H,br),1.25(6H,br),3.80(1H,m,5-H),5.
57(1H,ddd, J=15,12,1Hz 7-H),6.10(1H,dd,J=15,5Hz,
6-H),6.32(1H,dd,J=6,1Hz,11-H),6.86(1H,S,14-H),6.9
1(1H,d,J=6,8-H),7.34(5H,S,Ph),7.73(1H,d,J=6Hz,12
-H) 実施例10 化合物6122mg(0.22mmol)を乾燥ベンゼン0.4mに
溶かした。これに塩化第一銅48mg(0.48mmol)を加え
た。この混合物を攪拌しながら、DCC225mg(1.09mmo
l)を乾燥ベンゼン0.5mに溶かして加えた。TLC (ethyl acetate: hexane = 1: 2); Rf0.47,0.40 (40%) (20%) Spectral data Compound 12-1 TLC; Rf0.73, EtoAc / hex = 1/5 IR (liquid film, cm -1 ): 3070,2960,2860,1690,1620,1530,14
60,1440,1320,1250,1170,1140,1070,970,830,770,745,6
90 Compound 12-2 TLC; Rf0.47,0.40, EtoAc = 1/2 Low polarity component (E, Z type) IR (liquid film, cm -1 ): 3450,3070,2970,2940,2870,1680,16
15,1525,1440,1320,1220,1175,1120,1070,1050,970,82
0,750,695 H NMR; 0.89 (3H, br), 1.1-1.7 (6H, br), 4.35 (1H, m, 5-
H), 6.35 (1H, dd J = 6,2Hz, 11-H), 6.4 (1H, m, 7-H), 6.8-7.2
(3H, m, 6-H, 8-H, 14-H), 7.34 (5H, S, Ph), 8.01 (1H, d, J = 6H
z, 12-H) Highly polar component (E, E type) IR (liquid film, cm -1 ): 3450,2960,2945,2860,1680,1615,15
35,1440,1220,1185,1160,1125,975,860,820,750,690 H NMR; 0.88 (3H, br), 1.25 (6H, br), 3.80 (1H, m, 5-H), 5.
57 (1H, ddd, J = 15,12,1Hz 7-H), 6.10 (1H, dd, J = 15,5Hz,
6-H), 6.32 (1H, dd, J = 6,1Hz, 11-H), 6.86 (1H, S, 14-H), 6.9
1 (1H, d, J = 6,8-H), 7.34 (5H, S, Ph), 7.73 (1H, d, J = 6Hz, 12
-H) Example 10 122 mg (0.22 mmol) of compound 6 was dissolved in 0.4 m of dry benzene. To this was added 48 mg (0.48 mmol) of cuprous chloride. While stirring the mixture, DCC 225 mg (1.09 mmo
l) was dissolved in 0.5 m of dry benzene and added.
反応混合物を20℃で6時間攪拌した後、溶媒として酢
酸エチルを用いろ過し、ろ液を2回水洗した。The reaction mixture was stirred at 20 ° C. for 6 hours, filtered using ethyl acetate as a solvent, and the filtrate was washed twice with water.
常法によつて得られた油状粗生成物をシリカゲルクロマ
トグラフイー酢酸エチル:ヘキサン=1:10を用いて
精製し目的物(E型)13-194mg(収率80%)と副生
成物(Z型)13-210mg(収率9%)を得た。The oily crude product obtained by a conventional method was purified by silica gel chromatography using ethyl acetate: hexane = 1: 10 to obtain 94 mg of the desired product (E type) 13-1 (yield 80%) and by-products. (Z type) 13-2 10 mg (yield 9%) was obtained.
TLC(酢酸エチル:ヘキサン=1:4); Rf 13-2 0.74,13-1 0.62 実施例11 化合物13-175mg(0.14mmol)の塩化メチレン溶液4m
に−40℃でm−クロロ過安息香酸24mg(0.14mmol)を
加え30分間攪拌した後、重炭酸ソーダ水溶液1mを
加え反応液の温度を室温まで戻し、抽出し、抽出液を2
回水洗した。TLC (ethyl acetate: hexane = 1: 4); Rf 13-2 0.74, 13-1 0.62 Example 11 Compound 13-1 75 mg (0.14 mmol) of methylene chloride solution 4 m
After adding 24 mg (0.14 mmol) of m-chloroperbenzoic acid at −40 ° C. to the mixture and stirring for 30 minutes, 1 m of an aqueous sodium bicarbonate solution was added, the temperature of the reaction solution was returned to room temperature, extraction was performed, and the extract was extracted with 2
It was washed with water twice.
常法によつて得られた油状粗生成物14はそのまま次の反
応を行なつた。The crude oily product 14 obtained by a conventional method was directly subjected to the following reaction.
実施例12 油状粗生成物14のトルエン溶液2mを還流下で45分
攪拌したのち、トルエンを除去し、シリカゲルクロマト
グラフイー(酢酸エチル:ヘキサン=1:20)で不純
物を除き(ここでは精製はできない)粗生成物15-1を得
た。Example 12 After stirring 2 m of a toluene solution of the oily crude product 14 under reflux for 45 minutes, the toluene was removed, and impurities were removed by silica gel chromatography (ethyl acetate: hexane = 1: 20) (purification not possible here). The product 15-1 was obtained.
粗生成物15-1のアセトニトリル溶液2mに5%HF0.
3mを加え20℃で6時間攪拌した後、重炭酸ソーダ
水溶液で中和し、酢酸エチル5mを加え抽出し、抽出
液を2回水洗した。抽出液は常法により処理した後シリ
カゲルクロマトグラフイー(酢酸エチル:ヘキサン=
1:5)で精製し、目的物15-221mg(6からの収率4
8%)を得た。A solution of the crude product 15-1 in 2 m of acetonitrile was added with 5% HF0.
After adding 3 m and stirring at 20 ° C. for 6 hours, the mixture was neutralized with an aqueous sodium bicarbonate solution, 5 m of ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method and then subjected to silica gel chromatography (ethyl acetate: hexane =
1: 5) and the desired product 15-2 21 mg (yield from 6 4
8%).
TLC(酢酸エチル:ヘキサン=1:2); Rf 0.43 スペクトルデータ 化合物15-2 IR(液膜,cm-1):3450,2970,2950,2870,1685,1625,16
00,1535,1505,1230,1160,1130,985,830,730 化合物15-1 IR(液膜,cm-1):3070,3020,2960,2940,2870,1700,16
40,1585,1505,1470,1440,1360,1255,1225,1160,1135,10
90,980,935,840,800,780,760,690 実施例13 化合物7638mg(0.95mmol)を乾燥ベンゼン0.7mを
溶かした。これに塩化第一銅210mg(2.12mmol)を加え
た。この混合物を攪拌しながら、N,N′−ジシクロヘキ
シルカルボジイミド(DCC)994mg(4.82mmol)を乾
燥ベンゼン0.7mに溶かして加えた。反応混合物を2
0℃で4時間攪拌した後、溶媒として酢酸エチルを用い
ろ過し、ろ液を2回水洗した。TLC (ethyl acetate: hexane = 1: 2); Rf 0.43 spectral data Compound 15-2 IR (liquid film, cm -1 ): 3450,2970,2950,2870,1685,1625,16
00,1535,1505,1230,1160,1130,985,830,730 Compound 15-1 IR (liquid film, cm -1 ): 3070,3020,2960,2940,2870,1700,16
40,1585,1505,1470,1440,1360,1255,1225,1160,1135,10
90,980,935,840,800,780,760,690 Example 13 638 mg (0.95 mmol) of compound 7 was dissolved in 0.7 m of dry benzene. To this was added 210 mg (2.12 mmol) of cuprous chloride. While stirring this mixture, 994 mg (4.82 mmol) of N, N'-dicyclohexylcarbodiimide (DCC) dissolved in 0.7 m of dry benzene was added. 2 reaction mixtures
After stirring at 0 ° C for 4 hours, the mixture was filtered using ethyl acetate as a solvent, and the filtrate was washed twice with water.
常法によつて得られた油状粗生成物をシリカゲルクロマ
トグラフイー(酢酸エチル:ヘキサン=1:12)を用
い精製し、目的物16-1531mg(収率86%)と副生成
物16-213mg(収率2%)を得た。The crude oily product obtained by a conventional method was purified by silica gel chromatography (ethyl acetate: hexane = 1: 12) to obtain 531 mg of the desired product 16-1 (yield 86%) and a by-product 16- 2 13 mg (yield 2%) was obtained.
TLC(酢酸エチル:ヘキサン=1:3); Rf 16-2 0.68 16-1 0.61 実施例14 化合物16-1503mg(0.77mmol)の塩化メチレン溶液5m
に−40℃でm−クロロ安息香酸133mg(0.77mmol)
を加え30分間攪拌した後重炭酸ソーダ水溶液3mを
加え、反応液の温度を室温まで戻し、抽出し、抽出液を
2回水洗した。TLC (ethyl acetate: hexane = 1: 3); Rf 16-2 0.68 16-1 0.61 Example 14 Compound 16-1 503 mg (0.77 mmol) of methylene chloride solution 5 m
133 mg (0.77 mmol) of m-chlorobenzoic acid at -40 ° C
Was added and stirred for 30 minutes, 3 m of an aqueous sodium bicarbonate solution was added, the temperature of the reaction solution was returned to room temperature, extraction was performed, and the extract was washed twice with water.
常法によつて得られた油状粗生成物17は、そのまま次の
反応を行なつた。The oily crude product 17 obtained by a conventional method was directly subjected to the following reaction.
実施例15 油状粗生成物17のトルエン溶液5mを還流下で1時間
攪拌した後、トルエンを除去し、シリカゲルクロマトグ
ラフイー(酢酸エチル:ヘキサン=1:20)で不純物
を除き(ここでは完全には精製できなかつた。)粗生成
物18-1を得た。Example 15 After stirring 5 ml of a toluene solution of the oily crude product 17 under reflux for 1 hour, toluene was removed, and impurities were removed by silica gel chromatography (ethyl acetate: hexane = 1: 20) (here, it could be completely purified. The crude product 18-1 was obtained.
TLC(酢酸エチル:ヘキサン=1:4); Rf 0.77(E,E1型) 0.65(E,Z型) 0.58(Z,Z型) 実施例16 粗生成物18-1のアセトニトリル溶液3mに5%HF0.
4mを加え20℃で6時間攪拌した後、重炭酸ソーダ
水溶液で中和し、酢酸エチル5mを加え抽出し、抽出
液を2回水洗した。抽出液は、常法により処理した後シ
リカゲルクロマトグラフイー(酢酸エチル:ヘキサン=
8:1)で精製し、目的物18-2の2重結合の立体異性体
として三成分をそれぞれ得た。TLC (ethyl acetate: hexane = 1: 4); Rf 0.77 (E, E 1 type) 0.65 (E, Z type) 0.58 (Z, Z type) Example 16 A solution of the crude product 18-1 in 3 m of acetonitrile was added with 5% HF0.
After adding 4 m and stirring at 20 ° C. for 6 hours, the mixture was neutralized with an aqueous sodium bicarbonate solution, 5 m of ethyl acetate was added for extraction, and the extract was washed twice with water. The extract was treated by a conventional method and then subjected to silica gel chromatography (ethyl acetate: hexane =
8: 1) to obtain the three components as the double bond stereoisomer of the target product 18-2.
TLC(酢酸エチル:ヘキサン=20:1); それぞれの成分のスペクトルデータは次の通り。 TLC (ethyl acetate: hexane = 20: 1); The spectrum data of each component are as follows.
IR(液膜,cm-1):3400(OH),2940,2880,1680,1620,153
5,1505,1325,1220,1180,1050,975,870,830 nmr(δ);1.3-1.7(4H,m,2-H2,3-H2),3.56(2H,t,J=6H
z,1-H2),3.82(1H,q,J=6Hz,4-H),5.56(1H,ddd,J=1,11,
15Hz,6-H),6.06(1H,dd,J=6,15Hz,5-H),6.24(1H,dd,J=
1,6Hz,10-H),6.72(1H,d,J=11Hz,7-H),6.73(1H,S,13-
H),6.85-7.40(4H,m,C6H4),7.64(1H,d,J=6Hz,11-H) nmr(δ);1.64(4H,br,2-H2,3-H2),3.59(2H,br,1-H2),
4.30(1H,m,4-H),6.30(1H,d,J=6Hz,10-H)Ca.6.3(1H,m,6
-H),6.7-7.4(7H,m,5-H.7-H,13-H,C6H4),7.91(1H,d,J=6
Hz,11-H) nmr(δ);1.65,1.67(4H,br,2-H2,3-H2),3.61(2H,br,1-
H2),4.3(1H,m,4-H),6.19(1H,dd,J=6,15Hz,5-H)6.30(1
H,dd,J=6,1Hz,10-H),6.82(1H,d,J=11Hz,7-H),6.87(1
H,S,13-H),6.9-7.4(4H,m,C6H4),7.81(1H,dd,J=11,15H
z,6-H)7.91(1H,d,J=6Hz,11-H) 実施例17 化合物19332mg(0.63mmol)を乾燥ベンゼン0.5mに溶
かした。これに塩化第一銅138mg(1.39mmol)を加え
た。この混合物を攪拌しながら、N,N′−ジシクロヘキ
シルカルボジイミド(DCC)654mg(3.17mmol)を乾
燥ベンゼン0.5mに溶かして加えた。反応混合物を2
0℃で3時間30分攪拌した後、溶媒として酢酸エチル
を用いろ過し、ろ液を2回水洗した。 IR (liquid film, cm -1 ): 3400 (OH), 2940,2880,1680,1620,153
5,1505,1325,1220,1180,1050,975,870,830 nmr (δ); 1.3-1.7 (4H, m, 2-H 2 , 3-H 2 ), 3.56 (2H, t, J = 6H
z, 1-H 2 ), 3.82 (1H, q, J = 6Hz, 4-H), 5.56 (1H, ddd, J = 1,11,
15Hz, 6-H), 6.06 (1H, dd, J = 6,15Hz, 5-H), 6.24 (1H, dd, J =
1,6Hz, 10-H), 6.72 (1H, d, J = 11Hz, 7-H), 6.73 (1H, S, 13-
H), 6.85-7.40 (4H, m, C 6 H 4 ), 7.64 (1H, d, J = 6Hz, 11-H) nmr (δ); 1.64 (4H, br, 2-H 2 , 3-H 2 ), 3.59 (2H, br, 1-H 2 ),
4.30 (1H, m, 4-H), 6.30 (1H, d, J = 6Hz, 10-H) Ca.6.3 (1H, m, 6
-H), 6.7-7.4 (7H, m, 5-H.7-H, 13-H, C 6 H 4 ), 7.91 (1H, d, J = 6
Hz, 11-H) nmr (δ); 1.65,1.67 (4H, br, 2-H 2 , 3-H 2 ), 3.61 (2H, br, 1-
H 2 ), 4.3 (1H, m, 4-H), 6.19 (1H, dd, J = 6,15Hz, 5-H) 6.30 (1
H, dd, J = 6,1Hz, 10-H), 6.82 (1H, d, J = 11Hz, 7-H), 6.87 (1
H, S, 13-H), 6.9-7.4 (4H, m, C 6 H 4 ), 7.81 (1H, dd, J = 11,15H
z, 6-H) 7.91 (1H, d, J = 6Hz, 11-H) Example 17 332 mg (0.63 mmol) of compound 19 was dissolved in 0.5 m of dry benzene. To this was added 138 mg (1.39 mmol) of cuprous chloride. While stirring this mixture, 654 mg (3.17 mmol) of N, N'-dicyclohexylcarbodiimide (DCC) dissolved in 0.5 m of dry benzene was added. 2 reaction mixtures
After stirring at 0 ° C for 3 hours and 30 minutes, the mixture was filtered using ethyl acetate as a solvent, and the filtrate was washed twice with water.
常法によつて得られた油状粗生成物をシリカゲルクロマ
トグラフイー(酢酸エチル:ヘキサン=1:3)を用い
て精製し、目的物20-1 271mg(収率85%)と副生成物
20-2 9mg(収率3%)を得た。The crude oily product obtained by a conventional method was purified by silica gel chromatography (ethyl acetate: hexane = 1: 3) to obtain 271 mg of the desired product 20-1 (yield 85%) and a by-product.
20-29 mg (yield 3%) was obtained.
TLC(酢酸エチル:ヘキサン=1:1); Rf 20-2 0.61,20-1 0.57 スペクトルデータ IR(液膜,cm-1):3070,3010,2960,2870,1730,1690,16
40,1600,1580,1505,1480,1440,1370,1230,1170,1095,10
25,840,745,690 実施例18 化合物20-1 244mg(0.48mmol)の塩化メチレン溶液5
mに−40℃でm−クロロ過安息香酸83mg(0.48mmo
l)を加え30分間攪拌した後、重炭酸ソーダ水溶液2m
を加え反応液の温度を室温まで戻し、抽出し、抽出液
を2回水洗した。TLC (ethyl acetate: hexane = 1: 1); Rf 20-2 0.61, 20-1 0.57 Spectral data IR (liquid film, cm -1 ): 3070,3010,2960,2870,1730,1690,16
40,1600,1580,1505,1480,1440,1370,1230,1170,1095,10
25,840,745,690 Example 18 Compound 20-1 244 mg (0.48 mmol) of methylene chloride solution 5
m-chloroperbenzoic acid 83 mg (0.48 mmo at -40 ° C)
l) was added and stirred for 30 minutes, and then 2m aqueous solution of sodium bicarbonate
Was added, the temperature of the reaction solution was returned to room temperature, extraction was performed, and the extract was washed twice with water.
常法によつて得られた油状粗生成物21は、そのまま次の
反応を行なつた。The crude oil product 21 obtained by a conventional method was directly subjected to the following reaction.
実施例19 油状粗生成物21トルエン溶液10mを還流下で1時間
攪拌したのち、トルエンを除去しシリカゲルクロマトグ
ラフイー(酢酸エチル:ヘキサン=1:6)を用いて精
製し、目的物22161mg(収率84%)が得られた。Example 19 The oily crude product 21 Toluene solution (10 m) was stirred under reflux for 1 hour, toluene was removed, and the residue was purified by silica gel chromatography (ethyl acetate: hexane = 1: 6) to obtain the desired product 22 (161 mg, yield 84 %)was gotten.
TLC(酢酸エチル:ヘキサン=1:1); Rf 0.60, 0.51 (127mg) (34mg) (Z,E体) (EE体) スペクトルデータ 低極性成分 nmr(δ):2.01and2.05 Ca,2.00(2H,m,3-H2),2.34(2H,t,J=7Hz,2-H2),3.61(3H,
S,-COOCH3),5.41(1H,q,J=6Hz,4-H),5.9-6.3(1H,m,5-
H),6.36(2H,d,J=6Hz,10-H),6.5-8.0(8H,m,6,7,11,13-
H,C6H4) 高極性成分 nmr(δ):2.00 Ca,2.00(2H,m,3-H2),2.37(2H,t,J=7Hz,2-H2),3.63(3H,
S,-COOCH3),5.85(2H,m,4-H,5-H),6.36(1H,dd,J=2.6Hz,
11-H),6,7-7,5(7H,m,6,7,13-H,C6H4),7.98(1H,d,J=6H
z,11-H) IR(液膜,cm-1);1730,1690,1630,1600,1500,1370,12
35,1180,1160,1025,980,870,830TLC (ethyl acetate: hexane = 1: 1); Rf 0.60, 0.51 (127mg) (34mg) (Z, E form) (EE form) Spectral data Low polarity component nmr (δ): 2.01and2.05 Ca, 2.00 (2H, m, 3-H 2 ), 2.34 (2H, t, J = 7Hz, 2-H 2 ), 3.61 (3H,
S, -COOCH 3 ), 5.41 (1H, q, J = 6Hz, 4-H), 5.9-6.3 (1H, m, 5-
H), 6.36 (2H, d, J = 6Hz, 10-H), 6.5-8.0 (8H, m, 6,7,11,13-
H, C 6 H 4 ) High polarity component nmr (δ): 2.00 Ca, 2.00 (2H, m, 3-H 2 ), 2.37 (2H, t, J = 7Hz, 2-H 2 ), 3.63 (3H,
S, -COOCH 3 ), 5.85 (2H, m, 4-H, 5-H), 6.36 (1H, dd, J = 2.6Hz,
11-H), 6,7-7,5 (7H, m, 6,7,13-H, C 6 H 4 ), 7.98 (1H, d, J = 6H
z, 11-H) IR (liquid film, cm -1 ); 1730,1690,1630,1600,1500,1370,12
35,1180,1160,1025,980,870,830
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 // A61K 31/12 ADU 31/557 ADY ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location // A61K 31/12 ADU 31/557 ADY
Claims (4)
ルキル)シリルオキシ基,テトラヒドロピラニルオキシ
基,アセトキシ基または炭素数1〜6のアルキルオキシ
カルボニル基で置換されていてもよい炭素数1〜10の
アルキル基を、Arはアルキル基,ヒドロキシ基,アル
コキシ基,アルキルオキシカルボニル基およびハロゲン
原子からなる群から選ばれる少なくとも1種の基で置換
されていてもよい全炭素数6〜12のフェニル基を、記
号は単結合で2重結合に関してE体またはZ体を表わ
す。] で表わされる4−アリールメチレン−5−アルケニリデ
ン−2−シクロペンテノン類。1. The following formula [I]: [In the formula, R 1 is a hydroxy group, a tri (alkyl having 1 to 4 carbon) silyloxy group, a tetrahydropyranyloxy group, an acetoxy group or a carbon which may be substituted with an alkyloxycarbonyl group having 1 to 6 carbon. Ar having a number of 1 to 10 and Ar having a total of 6 to 10 carbon atoms which may be substituted with at least one group selected from the group consisting of an alkyl group, a hydroxy group, an alkoxy group, an alkyloxycarbonyl group and a halogen atom. The phenyl group of 12 represents a single bond in the E form or Z form with respect to the double bond. ] 4-Arylmethylene-5-alkenylidene-2-cyclopentenones represented by the formula:
ルである特許請求の範囲第1項記載の4−アリールメチ
レン−5−アルケニリデン−2−シクロペンテノン類。2. The 4-arylmethylene-5-alkenylidene-2-cyclopentenones according to claim 1, wherein Ar is phenyl or p-fluorophenyl.
ロキシブチルである特許請求の範囲第1項または第2項
記載の4−アリールメチレン−5−アルケニリデン−2
−シクロペンテノン類。3. 4-Arylmethylene-5-alkenylidene-2 according to claim 1 or 2, wherein R 1 is monohydroxypentyl or hydroxybutyl.
-Cyclopentenones.
ボニルプロピル基である特許請求の範囲第1項または第
2項記載の4−アリールメチレン−5−アルケニリデン
−2−シクロペンテノン類。4. The 4-arylmethylene-5-alkenylidene-2-cyclopentenones according to claim 1 or 2, wherein R 1 is a 1-acetoxy-3-ethoxycarbonylpropyl group.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60224919A JPH0641431B2 (en) | 1985-10-11 | 1985-10-11 | 4-Arylmethylene-5-alkenylidene-2-cyclopentenones |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60224919A JPH0641431B2 (en) | 1985-10-11 | 1985-10-11 | 4-Arylmethylene-5-alkenylidene-2-cyclopentenones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6287547A JPS6287547A (en) | 1987-04-22 |
| JPH0641431B2 true JPH0641431B2 (en) | 1994-06-01 |
Family
ID=16821220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60224919A Expired - Fee Related JPH0641431B2 (en) | 1985-10-11 | 1985-10-11 | 4-Arylmethylene-5-alkenylidene-2-cyclopentenones |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0641431B2 (en) |
-
1985
- 1985-10-11 JP JP60224919A patent/JPH0641431B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6287547A (en) | 1987-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO1987003593A1 (en) | Method for producing optically active periplanone-B | |
| JPH0560835B2 (en) | ||
| KR900004129B1 (en) | Intermediates for the production of phdophyllotoxin and related compounds and processes for the preparation | |
| JPH0251559B2 (en) | ||
| US4571428A (en) | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones | |
| US4625039A (en) | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates | |
| US4711895A (en) | 4-hydroxy-2-cyclopentenone, process for production thereof, pharmaceutical composition comprising it | |
| US4788319A (en) | Novel isocarbacyclins and processes for production thereof | |
| EP0338796B1 (en) | 2-substituted-2-cyclopentenones | |
| SU1277897A3 (en) | Method of producing 1,1-dioxo-6-brom(or-6,6-dibromine) penicillanoyloxymethyl ethers of 6-(2-azido-2-phenylacetamido)penicillanic acid | |
| JPH0641431B2 (en) | 4-Arylmethylene-5-alkenylidene-2-cyclopentenones | |
| US4360688A (en) | Precursors and synthesis of d1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates | |
| US4983753A (en) | Precursors and synthesis of di-(methyl)-16,16-(dimethyl)-11-alpha,15-alpha beta-dihydroxy-9-oxo-2,13-trans,trans-prostadienoates | |
| CA1307264C (en) | Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors | |
| US4107181A (en) | Useful prostaglandin intermediates | |
| JP2503073B2 (en) | 2-Substituted-2-cyclopentenones and osteogenic promoters or anticancer agents containing the same | |
| US4767853A (en) | Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof | |
| JPH029585B2 (en) | ||
| JPH0463056B2 (en) | ||
| US4474979A (en) | Synthesis of d1-(methyl)-16,16-(dimethyl-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans,trans-prostadienoates | |
| US5166369A (en) | Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates | |
| US4701536A (en) | Novel 10-membered ring compound and process for preparing the same | |
| JP2860506B2 (en) | Halogenoallyl alcohol derivatives | |
| CA1335669C (en) | 2,3-epoxycyclopentanones | |
| US4948885A (en) | Synthesis of azetidinones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |